TAROSIN tablets ZENTIVA
Active substance: rutoside
C05CA51 Cardiovascular system | Capillary stabilizing agents | Bioflavonoids
Indicated for: chronic venous insufficiency; capillary fragility
Find medicines for human use by name or active substance.
Browse by initial
221–240 of 1,317 medicines
Active substance: rutoside
C05CA51 Cardiovascular system | Capillary stabilizing agents | Bioflavonoids
Indicated for: chronic venous insufficiency; capillary fragility
Active substance: tolcapone
N04BX01 Nervous system | Dopaminergic agents | Other dopaminergic agents
Indicated for: Parkinson's disease
Active substance: tolcapone
N04BX01 Nervous system | Dopaminergic agents | Other dopaminergic agents
Indicated for: Parkinson's disease
Active substance: sodium aurothiomalate
M01CB01 Musculo-skeletal system | Specific antirheumatic agents | Gold preparations
Indicated for: rheumatoid arthritis
Active substance: sodium aurothiomalate
M01CB01 Musculo-skeletal system | Specific antirheumatic agents | Gold preparations
Indicated for: rheumatoid arthritis
Active substance: sodium aurothiomalate
M01CB01 Musculo-skeletal system | Specific antirheumatic agents | Gold preparations
Indicated for: rheumatoid arthritis
Active substance: levofloxacin
J01MA12 Antiinfectives for systemic use | Quinolone antibacterials | Fluoroquinolones
Indicated for: bacterial infections
Active substance: levofloxacin
J01MA12 Antiinfectives for systemic use | Quinolone antibacterials | Fluoroquinolones
Indicated for: bacterial infections
Active substance: levofloxacin
J01MA12 Antiinfectives for systemic use | Quinolone antibacterials | Fluoroquinolones
Indicated for: bacterial infections
Active substance: levofloxacin
J01MA12 Antiinfectives for systemic use | Quinolone antibacterials | Fluoroquinolones
Indicated for: bacterial infections
Active substance: carbamazepine
N03AF01 Nervous system | Antiepileptics | Antiepileptics | Carboxamide derivatives
Indicated for: epilepsy
Active substance: plants
R07AXN2 Respiratory system | Other respiratory system products | Other respiratory system products
Indicated for: herbal symptomatic treatment
Active substance: lavender
R05CB Respiratory system | Expectorants, excl. combinations with cough suppressants | Mucolytics
Indicated for: mild restlessness; minor sleep disorders
WHO (World Health Organization): Any substance or product that is used or is intended to be used to alter a physiological system or a pathological condition in the recipient's benefit.
Medicinal product: A substance or combination of substances used to treat or prevent disease, to restore, correct or modify physiological functions through pharmacological, immunological or metabolic action, or to make a medical diagnosis.
Active ingredient: A substance used in a medicine to produce a pharmacological, immunological or metabolic effect that restores, corrects or modifies physiological functions.
Excipients: Ingredients in a medicine other than its active substance. They can help stabilise the medicine or deliver the active substance to its intended site of action.
Original medicine: A medicine first authorised on the basis of a full dossier documenting its quality, safety and efficacy. It may serve as the reference medicine for a generic product.
Generic medicine: A medicine developed to be equivalent to an authorised reference medicine. It contains the same active substance or substances and is used at the same doses to treat the same diseases. Its inactive ingredients, name, appearance and packaging may differ.